Listening to biotech CEOs speak on company conference calls requires a special skill.

I don’t mean merely hearing the words spoken. That’s easy enough, especially since much of what CEOs say can be thrown into two basic verbal buckets. There are straightforward facts (“We reported $50 million in sales during the quarter”) that are just cut and paste from a press release anyone can read.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Everything Adam Feuerstein says is a RED FLAG. DO NOT BELIEVE A WORD THIS LYING STOCK MANIPULATOR SAYS. Mr Feuerstein has cost honest investors untold dollars by publishing “fake news” to discredit small Pharma companies for his own profit or for the profit of those who hired him. Mr Feuerstein should be in the same jail cell as that other lying weasel Martin Shkreli.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy